Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
05:06pm, Tuesday, 27'th Aug 2024
LOS ANGELES, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action
Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM
04:00pm, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
NEW YORK , Aug. 27, 2024 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed again
DexCom (DXCM) Accused of Misleading Investors - Hagens Berman
03:30pm, Tuesday, 27'th Aug 2024
DXCM Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / August 27, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses to
DexCom Stock May Gain on Expanded Reach After Stelo's US Launch
01:01pm, Tuesday, 27'th Aug 2024
DXCM announces that its OTC CGM, Stelo, is now available for purchase in the United States without a prescription.
Investors in DexCom, Inc. Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights – DXCM
12:55pm, Tuesday, 27'th Aug 2024
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM
11:15am, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
Stockholders In DexCom Inc Should Contact The Schall Law Firm About An Inquiry Into The Company's Potential Securities Fraud
11:00am, Tuesday, 27'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. ("
Can These 3 Nasdaq 100 Laggards Rebound in September?
09:26am, Tuesday, 27'th Aug 2024
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM
07:25am, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
NEW YORK CITY, NY / ACCESSWIRE / August 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, I
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follo
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Compa
NEW YORK , Aug. 27, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The
